Geoffrey Suleiman Husaunndee

Last updated
2 weeks ago
Watch for changes

Where they hold approval

Firms where this individual holds — or has held — an FCA-approved role.

  • Astute Financial & Lifestyle Planning Limited (no longer approved here)

    FRN 437966

    • Responsible for Insurance Distribution (10 Sep 2021 to 8 Feb 2024)
    • SMF3 Executive Director (10 Sep 2021 to 8 Feb 2024)
    • SMF17 Money Laundering Reporting Officer (MLRO) (10 Sep 2021 to 8 Feb 2024)
    • SMF16 Compliance Oversight (10 Sep 2021 to 8 Feb 2024)
  • Chamberlyns Limited (no longer approved here)

    FRN 183524

    • SMF16 Compliance Oversight (8 Sep 2021 to 8 Feb 2024)
    • SMF17 Money Laundering Reporting Officer (MLRO) (8 Sep 2021 to 8 Feb 2024)
    • [FCA CF] Manager of certification employee (9 Dec 2019 to 30 Apr 2024)
    • SMF3 Executive Director (9 Dec 2019 to 8 Feb 2024)
    • [FCA CF] Client dealing (9 Dec 2019 to 30 Apr 2024)
    • [FCA CF] Functions requiring qualifications (9 Dec 2019 to 30 Apr 2024)
    • Responsible for Insurance Distribution (1 Oct 2018 to 8 Feb 2024)
    • Responsible for Insurance Mediation (7 Jan 2014 to 30 Sep 2018)
    • CF1 Director (20 May 2009 to 8 Dec 2019)
    • CF30 Customer (20 May 2009 to 8 Dec 2019)
  • LONSDALE FINANCIAL CONSULTING LIMITED (no longer approved here)

    FRN 189974

    • SMF16 Compliance Oversight (2 Jul 2020 to 8 Feb 2024)
    • Responsible for Insurance Distribution (2 Jul 2020 to 8 Feb 2024)
    • SMF17 Money Laundering Reporting Officer (MLRO) (2 Jul 2020 to 8 Feb 2024)
    • SMF3 Executive Director (2 Jul 2020 to 8 Feb 2024)
    • [FCA CF] Functions requiring qualifications (9 Dec 2019 to 30 Apr 2024)
    • [FCA CF] Manager of certification employee (9 Dec 2019 to 30 Apr 2024)
    • [FCA CF] Client dealing (9 Dec 2019 to 30 Apr 2024)
  • 5 Point Financial Planning Ltd (no longer approved here)

    FRN 231278

    • (11)Employed By (5 Feb 2004 to 26 Dec 2007)

Recent activity

Updates to this individual's record on the FCA register.

No changes recorded yet.